REGN

Regeneron Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality9/10
  • Growth↓ 3/10
  • Momentum↑ 6/10
Regeneron Pharmaceuticals sales and earnings growth
REGN Growth
Neutral
  • Revenue Y/Y↓ 0.99%
  • EPS Y/Y↑ 5.31%
  • FCF Y/Y↑ 10.74%
Regeneron Pharmaceuticals gross and profit margin trends
REGN Profitability
Good
  • Gross margin ↑ 85.40%
  • EPS margin↑ 31.40%
  • ROIC↑ 15.60%
Regeneron Pharmaceuticals recent dividend growth
REGN Dividends
  • Dividend yield 0.48%
  • Growth 3Y↓ 0.00%
  • Payout ratio↑ 8%
Regeneron Pharmaceuticals net debt vs free cash flow
REGN Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 120.4

Regeneron Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗